PMBCL

Clinical trials for PMBCL explained in plain language.

Never miss a new study

Get alerted when new PMBCL trials appear

Sign up with your email to follow new studies for PMBCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Can a Macrophage-Targeting drug supercharge CAR-T therapy?

Disease control Not yet recruiting

This trial tests whether adding a drug called axatilimab to standard CAR-T cell therapy can improve outcomes for people with high-risk large B-cell lymphomas. Axatilimab works by conditioning macrophages, a type of immune cell, to potentially help the CAR-T cells fight cancer mor…

Matched conditions: PMBCL

Phase: PHASE1 • Sponsor: Northside Hospital, Inc. • Aim: Disease control

Last updated Jun 27, 2026 13:07 UTC

PMBCL

Get alerted when new PMBCL trials appear

Can a Macrophage-Targeting drug supercharge CAR-T therapy?